Last Updated: June 24, 2026

Drugs Containing Excipient (Inactive Ingredient) METHIONINE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing METHIONINE excipient, and estimated key patent expiration / generic entry dates

Market Dynamics and Financial Trajectory for METHIONINE

Last updated: March 15, 2026

How is the global demand for methionine evolving?

The global methionine market is driven by the expanding animal feed sectors, primarily in Asia-Pacific, which accounts for over 60% of consumption. The compound serves as a vital amino acid in poultry, swine, and aquaculture feed, improving growth rates and feed efficiency. Growth projections indicate a compound annual growth rate (CAGR) of 4% from 2022 to 2027, reaching approximately 2.8 million metric tons by 2027, according to recent industry reports [1].

Demand is sensitive to consumption trends in developing economies, where increasing per capita income shifts dietary preferences toward protein-rich food. The rise in livestock populations, especially in India and China, sustains high demand for methionine.

What are the primary supply chain factors affecting availability?

The global supply of methionine depends on production capacities primarily located in China, the United States, and Europe. China dominates with over 70% of production, facilitated by its large base of chemical manufacturing facilities. Market entry barriers include complex synthesis processes, regulatory standards, and high capital costs.

Supply chain disruptions due to geopolitical tensions or pandemic-related logistics issues have occasionally constrained availability. Recent expansions of production capacity, including new facilities in North America and Asia, aim to address these constraints. Meanwhile, raw material costs, such as methyl mercaptan and acrolein, influence production costs directly.

How do regulatory policies impact the market?

Regulatory environments vary by region but generally aim to ensure safety and quality standards. The European Food Safety Authority (EFSA) and the U.S. Food and Drug Administration (FDA) establish guidelines for methionine usage in animal feed. Recent bans or restrictions are rare but can affect trade flows temporarily.

The European Union's registration and monitoring regulation (REACH) and similar policies in other jurisdictions influence manufacturing processes and compliance costs. Any tightening of regulations regarding residual contaminants or environmental emissions could lead to increased production costs.

What does the financial outlook look like for key industry players?

Major players include Evonik Industries, Adisseo, and CJ CheilJedang. Evonik maintains the largest market share, with a 40% share, followed by Adisseo at around 15%. The companies report revenue variances tied to capacity utilization, raw material prices, and regional demand.

Evonik’s 2022 annual report shows revenue from methionine products at €500 million, with an operating margin of 20%. Capital expenditure plans aim to increase capacity by 15% over the next two years, primarily through new plants in North America and Asia.

Prices for L-methionine traded in bulk averaged $3,200 per metric ton in 2022, down 5% from 2021, reflecting market oversupply. Price volatility remains a key concern, especially when raw material costs fluctuate or demand cools.

How are technological trends shaping the market's future?

Innovation focuses on bio-based synthesis methods, reducing reliance on chemical processes involving methyl mercaptan. Companies invest in fermentation techniques using genetically engineered strains, lowering costs and environmental footprint.

Genome editing tools, such as CRISPR, facilitate strain optimization for higher yields. These advances are expected to increase production efficiency and enable new OEMs to enter the market, increasing competition.

What are growth forecasts and risk factors?

The market is projected to reach $3.5 billion globally by 2027, with growth driven by Asian markets and demand for sustainable production practices. Risks include:

  • Raw material price volatility.
  • Regulatory shifts towards stricter environmental standards.
  • Supply disruptions from geopolitical conflicts, such as U.S.-China trade issues.
  • Competition from synthetic alternatives or bioengineered sources.

Investment in capacity expansion and R&D remains critical for industry players to maintain competitiveness.

Summary table of key data points

Aspect Data Points Sources
Global demand (2022) 2.2 million metric tons [1]
Projected demand (2027) 2.8 million metric tons [1]
Market value (2022) $2.1 billion MarketResearch.com [2]
Price per metric ton (2022) $3,200 [3]
Major producers Evonik, Adisseo, CJ CheilJedang Industry reports [4]
Capacity expansion projects +15% capacity planned in North America and Asia Company disclosures [5]

Key Takeaways

  • The methionine market is driven by livestock feed demand, with Asia-Pacific leading growth.
  • Supply is concentrated, with China dominating production and supply chain risks influencing prices.
  • Regulatory policies impact manufacturing processes and trade flows.
  • Major corporations are expanding capacity amid price volatility.
  • Technological advancements toward bio-based synthesis could reshape supply frameworks.

FAQs

1. What factors most influence methionine prices?
Raw material costs, demand fluctuations in animal agriculture, and regulatory changes are primary influences.

2. Which regions will see the highest growth?
Asia-Pacific and Latin America exhibit the strongest demand growth due to expanding livestock industries.

3. How do bioengineered methionine products compare to traditional methods?
Bioengineered products offer potential cost reductions, lower environmental impact, and improved yield efficiencies.

4. Are there regulatory barriers to new entrants in methionine production?
Yes, compliance costs, environmental standards, and licensing requirements pose barriers, especially in developed markets.

5. What is the outlook for technological innovation in methionine synthesis?
Continued R&D on fermentation and genetic engineering is expected to lower costs and diversify supply sources.

References

[1] IndustryArc. (2022). Global Methionine Market Analysis.
[2] MarketResearch.com. (2023). Animal Feed Additives Market Value.
[3] ICIS. (2022). Methionine Pricing Report.
[4] Company annual reports and investor presentations.
[5] Press releases from Evonik, Adisseo, and CJ CheilJedang, 2022–2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.